Holen Sie sich die Stockscreener-App
1.99
1.49%
-0.03
Handel nachbörslich:
1.96
-0.03
-1.51%
Schlusskurs vom Vortag:
$2.02
Offen:
$2.02
24-Stunden-Volumen:
392.17K
Relative Volume:
0.17
Marktkapitalisierung:
$91.85M
Einnahmen:
$16.77M
Nettoeinkommen (Verlust:
$-11.87M
KGV:
-4.1965
EPS:
-0.4742
Netto-Cashflow:
$-5.90M
1W Leistung:
+5.29%
1M Leistung:
+34.46%
6M Leistung:
+348.20%
1J Leistung:
+232.16%
1-Tages-Spanne:
$1.915
$2.05
1-Wochen-Bereich:
$1.766
$2.12
52-Wochen-Spanne:
$0.30
$2.41
Immunoprecise Antibodies Ltd Stock (IPA) Company Profile
Firmenname
Immunoprecise Antibodies Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie IPA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IPA
Immunoprecise Antibodies Ltd
|
1.99 | 93.23M | 16.77M | -11.87M | -5.90M | -0.4742 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-12-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-25 | Eingeleitet | The Benchmark Company | Buy |
Immunoprecise Antibodies Ltd Aktie (IPA) Neueste Nachrichten
ImmunoPrecise Antibodies Ltd. Reaches Critical Trendline SupportJuly 2025 Rallies & Daily Profit Maximizing Tips - beatles.ru
ImmunoPrecise Antibodies Maintains Buy Rating on Strong Canadian Growth and Strategic Divestment - AInvest
Immunic, Inc. shares fall 1.43% after-hours as ImmunoPrecise Antibodies Ltd. reports earnings miss and auditor raises 'going concern' doubt. - AInvest
Angi (ANGI) Q2 Revenue Beats by 6% - AOL.com
Inmune Bio Inc. shares fall 1.09% after-hours as ImmunoPrecise Antibodies Ltd. reports earnings miss and auditor raises 'going concern' doubt. - AInvest
Sensei (SNSE) Q2 Loss Narrows 31% - AOL.com
Aurinia (AUPH) Q2 Revenue Jumps 22% - AOL.com
ImmunoPrecise Antibodies Divests Netherlands Facilities to AVS Bio - citybiz
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q4 2025 Earnings Call Transcript - MSN
Beta Bionics (BBNX) Q2 Revenue Soars 54% - AOL.com
ImmunoPrecise Antibodies divests Netherlands facilities to AVS Bio - MSN
AVS Bio, an Arlington Capital Partners Portfolio Co. Acquires ImmunoPrecise Antibodies Europe - citybiz
ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation - Silicon Canals
AVS Bio, an Arlington Capital Partners Portfolio Company, Expands Antibody Discovery and Protein Production Capabilities With Acquisition of ImmunoPrecise Antibodies Europe From ImmunoPrecise Antibodies Ltd. - Silicon Canals
ImmunoPrecise Antibodies Divests Dutch Subsidiary to Focus on AI Innovation - TipRanks
ImmunoPrecise Antibodies sells Netherlands subsidiary to AVS Bio for $12m - Investing.com Australia
TR | OpenAI4o Initiates ImmunoPrecise Antibodies(IPA.US) With Hold Rating, Announces Target Price $2 - 富途牛牛
Day One (DAWN) Q2 Revenue Jumps 313% - AOL.com
Prothena Q2 Revenue Drops 97% - AOL.com
Agilon Health (AGL) Q2 Revenue Falls 6% - AOL.com
ImmunoPrecise (IPA) Q4 2025 Earnings Transcript - Mitrade
ITRM Reports Results - AOL.com
Idexx (IDXX) Q2 Revenue Jumps 11% - AOL.com
What institutional investors are buying ImmunoPrecise Antibodies Ltd. stockUnstoppable trading performance - Jammu Links News
What catalysts could drive ImmunoPrecise Antibodies Ltd. stock higher in 2025High-yield market plays - Jammu Links News
ImmunoPrecise Antibodies Ltd. Stock Analysis and ForecastSuperior risk-adjusted returns - Jammu Links News
What are analysts’ price targets for ImmunoPrecise Antibodies Ltd. in the next 12 monthsDynamic growth stocks - Jammu Links News
What drives ImmunoPrecise Antibodies Ltd. stock priceTremendous wealth creation - Jammu Links News
What is ImmunoPrecise Antibodies Ltd. company’s growth strategyExtraordinary market timing - Jammu Links News
What makes ImmunoPrecise Antibodies Ltd. stock price move sharplyInvest smarter with advanced market data - Jammu Links News
What are the latest earnings results for ImmunoPrecise Antibodies Ltd.Build a diversified portfolio for maximum returns - Jammu Links News
ImmunoPrecise Antibodies Announces October 2025 Annual Meeting Details - AInvest
Why is ImmunoPrecise Antibodies Ltd. stock attracting strong analyst attentionWealth Building Planner With Proven Results - Jammu Links News
ImmunoPrecise Antibodies Announces Details for October 2025 Annual Meeting - TipRanks
Does ImmunoPrecise Antibodies Ltd. stock perform well during market downturnsFinancial News Updates For Consistent Profits - Jammu Links News
What does recent volatility data suggest for ImmunoPrecise Antibodies Ltd.Technical Entry Plan with Risk Minimization - Newser
Is ImmunoPrecise Antibodies Ltd. stock bottoming outFree Accurate Buy Point for Momentum Stocks - Newser
Is ImmunoPrecise Antibodies Ltd. stock ready for a breakoutWeekly Chart-Based Forecast for Traders - Newser
ImmunoPrecise Antibodies Full Year 2025 Earnings: Misses Expectations - sg.finance.yahoo.com
How Efficient Is ImmunoPrecise Antibodies Ltd. at Controlling Operating CostsTechnical Trade Plan with Entry Checklist - Newser
Is ImmunoPrecise Antibodies Ltd. forming a reversal patternFree Swing Setup With Technical Confirmation - Newser
ImmunoPrecise Antibodies Ltd (IPA) Q4 2025 Earnings Call Highlights: Record Revenue and ... By GuruFocus - Investing.com Canada
ImmunoPrecise Antibodies Ltd (IPA) Q4 2025 Earnings Call Highlights: Record Revenue and ... - Yahoo Finance
Detecting support and resistance levels for ImmunoPrecise Antibodies Ltd.Short Term Opportunity Finder with Tools - Newser
ImmunoPrecise Antibodies Ltd. Reports Strategic Focus Amid Financial Challenges - TipRanks
Immunoprecise Antibodies Q4 2025 Earnings Call Transcript: Financial Performance, Strategic Initiatives, and Operational Highlights - AInvest
ImmunoPrecise Antibodies Reports Record Revenue and Growth - TipRanks
ImmunoPrecise Antibodies Q4 2025 Earnings Call Transcript - MarketBeat
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates - MSN
What technical models suggest about ImmunoPrecise Antibodies Ltd.’s comebackFree Fundamental Winners With Safe Entry Plan - Newser
Investors ignore increasing losses at ImmunoPrecise Antibodies (NASDAQ:IPA) as stock jumps 15% this past week - simplywall.st
Finanzdaten der Immunoprecise Antibodies Ltd-Aktie (IPA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):